Fendrix

Fendrix is a vaccine designed to prevent hepatitis B infection. It contains Aluminium Phosphate and Hepatitis B Surface Antigen, adjuvanted by AS04C. This intramuscular vaccine is manufactured by GlaxoSmithKline Biologicals S.A.

Fendrix is primarily used for the prevention of hepatitis B virus (HBV) infection. It is administered to individuals who are at risk of contracting the virus, such as those with chronic liver disease or healthcare workers. The vaccine works by stimulating the body's immune response to the hepatitis B surface antigen, helping to build immunity against the virus.

Common effects of Fendrix may include mild soreness, redness, or swelling at the injection site. Some individuals might experience temporary fatigue, headache, or mild fever following vaccination. These effects are generally short-lived and resolve on their own.

Fendrix should be administered by healthcare professionals experienced in vaccination procedures. It is important to inform your healthcare provider about any allergies or medical conditions before receiving the vaccine. Individuals with a history of severe allergic reactions to previous hepatitis B vaccines or any of its components should avoid Fendrix.

Fendrix may interact with other medications or vaccines. It is advisable to discuss any current medications or recent vaccinations with a healthcare provider before receiving Fendrix. Alcohol consumption and certain immune-suppressing drugs might affect the vaccine's efficacy.